0001181431-12-007985.txt : 20120213 0001181431-12-007985.hdr.sgml : 20120213 20120213063447 ACCESSION NUMBER: 0001181431-12-007985 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120201 FILED AS OF DATE: 20120213 DATE AS OF CHANGE: 20120213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YACHMETZ PHILIP K CENTRAL INDEX KEY: 0001250318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12595115 MAIL ADDRESS: STREET 1: 501 LAFAYETTE AVE CITY: WYCKOFF STATE: NJ ZIP: 07481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd333862.xml X0304 4 2012-02-01 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001250318 YACHMETZ PHILIP K SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, General Counsel Common Stock, $.01 par value 2012-02-01 4 A 0 50000 2.26 A 239024 D Option to Purchase Common Stock, $01 par value 2.26 2012-02-01 4 A 0 100000 2.26 A 2013-02-01 2022-02-01 Common Stock, $.01 par value per share 100000 100000 D The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates. These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates. /s/ Irina Ishak for Philip K. Yachmetz 2012-02-13